Vericel Corp — Director's Dealing 2023

Feb 8, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vericel Corp (VCEL)
CIK: 0000887359
Period of Report: 2023-02-06

Reporting Person: Hopper Jonathan Mark (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-06	Common Stock	M	650	—	Acquired	49722	Direct
2023-02-06	Common Stock	F	310	$30.60	Disposed	49412	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-06	Restricted Stock Unit	$	M	650	Disposed		Common Stock (650)	Direct

Footnotes

F1: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 6, 2019.

F2: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

F3: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs.

F4: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.

F5: No expiration date for this type of award.

F6: The Fair Market Value of the vested derivative securities is $30.60 per share.